02 Mar 2022 V-Bio Ventures’ portfolio company Syndesi Therapeutics acquired by AbbVie to strengthen its neuroscience portfolio Member news
15 Feb 2022 Verhaert acquires Academy for Corporate Entrepreneurship to help customers boost their capacity to innovate Member news
06 Jan 2022 Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis Member news
06 Sep 2021 Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities Member news
20 Jan 2021 Blue Matter announces acquisition of AIM, a leading European supply chain consulting firm Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
